比较每日两次和一次口服Genz-112638治疗对已接受每日两次治疗达到临床稳定的I型戈谢病患者影响的III期临床研究
[Translation] Phase III study comparing the effects of twice-daily and once-daily oral Genz-112638 in patients with type I Gaucher disease who have been clinically stable on twice-daily therapy
在使用Genz-112638每日两次口服治疗达到临床稳定的I型戈谢病患者中,比较每日一次给药相对于每日两次给药的疗效和安全性,评价药物游离碱基Genz-99067的药代动力学。
[Translation] To compare the efficacy and safety of once-daily dosing versus twice-daily dosing in patients with type I Gaucher disease who are clinically stable on twice-daily oral therapy with Genz-112638, evaluating the drug free base Genz- Pharmacokinetics of 99067.
100 Clinical Results associated with Genzyme (Shanghai) Biopharmaceutical Service Co Ltd
0 Patents (Medical) associated with Genzyme (Shanghai) Biopharmaceutical Service Co Ltd
100 Deals associated with Genzyme (Shanghai) Biopharmaceutical Service Co Ltd
100 Translational Medicine associated with Genzyme (Shanghai) Biopharmaceutical Service Co Ltd